Early research (Phase 1)Study completedNCT02123472What this trial is testingCephalexin Liquid for Pediatrics in Healthy Adults ParticipantsWho this might be right forHealthy Volunteers Eli Lilly and Company 28
Not applicableStudy completedNCT01508039What this trial is testingImmunological Effects From Intranasal Chitin Micro-ParticlesWho this might be right forHealthy University of Aarhus 14
Early research (Phase 1)Study completedNCT02104765What this trial is testingLY2951742 in Healthy Japanese and Caucasian ParticipantsWho this might be right forMigraine Disorders Eli Lilly and Company 45
Early research (Phase 1)WithdrawnNCT03131700What this trial is testingBioequivalence and Safety Study of Bevacizumab-biosimilar (RPH-001) Compared to Bevacizumab-innovatorWho this might be right forHealthy TRPHARM
Early research (Phase 1)Looking for participantsNCT06809400What this trial is testingLY4006896 in Healthy Participants and Participants With Parkinson's DiseaseWho this might be right forParkinson Disease Eli Lilly and Company 127
Early research (Phase 1)Study completedNCT02579707What this trial is testingFood Effect Study of AG120 in Healthy SubjectsWho this might be right forHealthy Agios Pharmaceuticals, Inc. 36
Early research (Phase 1)Study completedNCT01153607What this trial is testingEvaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy VolunteersWho this might be right forDiagnostic Imaging Life Molecular Imaging SA 24
Early research (Phase 1)Study completedNCT02316756What this trial is testingA Single Ascending Dose Study To Evaluate Safety And Pharmacokinetics Of Compound PF-06648671 In Healthy SubjectsWho this might be right forHealthy Subjects Pfizer 18
Early research (Phase 1)Study completedNCT04204902What this trial is testingBioequivalence of 5 Tablets of 100 mg Versus 2 Tablets of 250 mg TF3 of TepotinibWho this might be right forHealthy Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 18
Early research (Phase 1)Study completedNCT02348372What this trial is testingStudy to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy SubjectsWho this might be right forAnaemia GlaxoSmithKline 34
Early research (Phase 1)Study completedNCT02340572What this trial is testingFirst-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRS-080Who this might be right forHealthy Pieris Pharmaceuticals GmbH 48
Early research (Phase 1)Study completedNCT01814839What this trial is testingA Phase 1, Single- and Multi-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered ALN-TTRSC (Revusiran) in Healthy VolunteersWho this might be right forTTR-mediated Amyloidosis Alnylam Pharmaceuticals 85
Early research (Phase 1)Study completedNCT04734275What this trial is testingStudy to Assess Relative Bioavailability and Safety of AZD5718 in Healthy VolunteersWho this might be right forChronic Kidney Disease AstraZeneca 16
Early research (Phase 1)Study completedNCT02277600What this trial is testingAntiretroviral Drug-Drug Interaction Study in Healthy Volunteers (DDI)Who this might be right forInfection, Human Immunodeficiency Virus ViiV Healthcare 32
Early research (Phase 1)Study completedNCT01766245What this trial is testingA Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing ProcessesWho this might be right forDiabetesHealthy Novo Nordisk A/S 28
Early research (Phase 1)Study completedNCT06008028What this trial is testingEvaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fasting Conditions in Healthy VolunteersWho this might be right forHypertension Boryung Pharmaceutical Co., Ltd 57
Early research (Phase 1)Not Yet RecruitingNCT07248839What this trial is testingAssess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic ImpairmentWho this might be right forHealthy VolunteersHepatic Impairment Bristol-Myers Squibb 24
Early research (Phase 1)Study completedNCT05533801What this trial is testingDemonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy ParticipantsWho this might be right forHealthy Volunteers Eisai Inc. 160
Early research (Phase 1)Study completedNCT01487512What this trial is testingEffect of Dose on the Pharmacokinetics of OROS Hydromorphone Under Fasted Conditions in Healthy Taiwanese ParticipantsWho this might be right forHealthy Volunteers Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 29
Early research (Phase 1)Study completedNCT01568281What this trial is testingBioequivalence Study Comparing Arimidex Tablet and Anastrozole ODF in Japanese Healthy Male SubjectsWho this might be right forSafetyPharmacokinetics AstraZeneca 58